Digital Guide: PARP Inhibitors for Ovarian Cancer - Louisville

Findings suggest that in women with specific gene mutations or biomarkers there was a significant survival benefit with this combination therapy.

PARP inhibitors have significant benefit for recurrent ovarian cancers or for patients who have finished chemotherapy as a maintenance therapy

PARP inhibitors offer great promise to ovarian cancer patients. However experts explain that these "game-changing" drugs are not without their side effects.

Experts explain the side effects of bevacizumab, when it is used for ovarian cancer treatment, and how it differs from other anti-cancer drugs.

Since ovarian cancer cells can be stubborn, most women will begin maintenance therapy after initial treatment to help prevent recurrence.

PARP inhibitors, like chemotherapy, come with a host of side effects, most of which can be easily managed